Sensitivity of the oral clonidine test and the oral guanfacine test (alpha-2-adrenergic agonists) as pharmacological stimuli of growth hormone. Effects of plasma cortisol concentrations;Sensibilidad del test de clonidina y test de guanfacina (agonistas α-2-adrenergicos) como estimulos farmacologicos de la hormona de crecimiento. Efectos sobre el cortisol plasmatico

Anales Espanoles de Pediatria

Volumn 45, Issue 6, 1996, Pages 575-578

  Dura Trave T ^a,c   Juste Ruiz, M ^a   Gonzalez Montero R ^a   Gutierrez Teran M ^a   Mauri Dot, M ^b   Moya Benavent, M ^a  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^b UNIVERSITY OF ALICANTE   (Spain)

^c NONE   (Spain)

Author keywords

2 adrenergic agonists; blood pressure; growth hormone; oral clonidine test; oral guanfacine test; plasma cortisol concentration; short stature

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; GROWTH HORMONE; GUANFACINE; HYDROCORTISONE;

ARTICLE; BLOOD PRESSURE; CHILD; CLINICAL ARTICLE; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; HYDROCORTISONE BLOOD LEVEL; LABORATORY TEST; MALE; ORAL DRUG ADMINISTRATION; SHORT STATURE;

ADRENERGIC ALPHA-AGONISTS; CHILD; CLONIDINE; FEMALE; GROWTH DISORDERS; GUANFACINE; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; MALE; SENSITIVITY AND SPECIFICITY;

EID: 0030484392     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Diéguez C, Page MD, Scanlon MF. Growth hormone neuroregulation and its alterations in disease states. Clin Endocrinol 1988;28:109-143.
2. Casanueva FF. Physiology of growth hormone secretion and action. Endocrinol Metab Clin North Amer 1992;21:483-517.
3. Ghigo E, Arvat E, Bellone J, Ramunni J, Camanni F. Neurotransmitter control of growth hormone secretion in humans. J Pediatr Endocrinol 1993;6:263-266.
4. Vance ML. Metabolic status and growth hormone secretion in man. J Pediatr Endocrinol 1993;6:267-272.
5. Argente J, Pozo J, Barrios V. Neurorregulación de la hormona de crecimiento. An Esp Pediatr 1992;36(Supl 50):19-33.
6. Lancranjan I, Marbach P. New evidence for growth hormone modulation by the α-adrenergic system in men. Metabolism 1977;26:1225-1230.
7. Lal S, Tolis G, Martin JB, Brown GM, Guyda H. Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone in the serum of normal men. J Clin Endocrinol Metab 1975;41:827-832.
8. Fraser NC, Seth J, Brown NS. Clonidine is a better test for growth hor-mone deficiency than insulin hypoglycaemia. Arch Dis Child 1983,58:355-358.
9. Rodríguez-Arnao MD, Rodriguez J, Apaolaza I, Gómez-Pan A. Diagnóstico del déficit de hormona de crecimiento. En: Retrasos del crecimiento. Moreno B, Tresguerres JAF (eds). Madrid: Ediciones Díaz de Santos S.A. 1992; págs. 351-382.
10. García ML, Rodriguez MD, Lorenzo L, Mancheńo E, Teruel MC, Gómez A. Valoración de hormona de crecimiento: comparación entre un estímulo fisiológico (ejercicio) y estímulos farmacológicos (clonidina/guanfacina). An Esp Pediatr 1989;30:163-165.
11. Castro-Magaña M, Angulo M, Fuentes B, Castelar E, Cañas A, Espinosa B. Effect of prolonged clonidine administration on growth hormone concentrations and rate of linear growth in children with constitutional growth delay. J Pediatr 1986;109:784-787.
12. Moreno-Esteban B, Monereo S, Rodríguez P, Moreno FJ, Tresguerres JAF. One year of treatment with clonidin in children with CGD. J Endocr Invest 1991;14:75-79.
13. Devesa J, Arce V, Lois N, Tresguerres JAF, Lima L. α-2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone trough an inhibition of hypothalamic somatostatin release in normal men. J Clin Endocrinol Metab 1990;71:1581-1588.
14. Gil-Ad I, Topper E, Laron Z. Oral clonidine as a growth hormone stimulation test. Lancet 1979;ii:278-280.
15. Gurpide N, Durà T, Moya M. Importancia de la monitorización continua durante la estimulación de la hormona de crecimiento (test de clonidina). Enfermería Científica 1992;124-125:23-36.
16. Lanes R, Hurtado E. Oral clonidine -an effective growth hormone-releasing agent in prepuberal subjects. J Pediatr 1982;100:710-714.
17. Tanner JM, Whitehouse RJ, Cameron N, Marshall WA, Healy MJR, Goldstein H. Assessment of skeletal maturity and prediction of adult height (TW2 method). London: Academic Press Inc. 1983.
18. Loche S, Cambiaso P, Setzu S, Carta D, Marini R, Borrelli P, Cappa M. Final height after growth hormone therapy in non-growth-hormone-deficient children with short stature. J Pediatr 1994;125:196-200.
19. Garagorri JM. Tallas bajas variantes de la normalidad. En: Crecimiento y desarrollo humanos y sus trastornos. Bueno M (ed). Madrid: Ediciones Ergon S.A. 1993; págs. 105-119.
20. Tannenbaum GS, Ling N. The interrelationship of growth hormone GH-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. Endocrinology 1984;115:1952-1957.
21. Milner RDG, Burns EC. Investigation of suspected growth hormone deficiency. Arch Dis Child 1982;57:944-947.
22. Brook CGD, Hindmarsh PC. Test for growth hormone secretion. Arch Dis Child 1991;66:85-87.
23. King JM, Price DA. Sleep-induced growth hormone release-evaluation of a simple test for clinical use. Arch Dis Child 1983;58:220-222.
24. Paalayen K, Crock P, Pianosi P, Coates A, Weitzner G, Schiffrin A. Growth hormone response in very short children. Clin Invest Med 1991:14:331-337
25. Ranke MB, Haber P. Pruebas de estimulación de la hormona de crecimiento. En: Diagnóstico endocrinólogico funcional en niños y adolescentes. Ranke MB (ed). Madrid: Ediciones Díaz Santos S.A. 1993; págs. 71-87.
26. The Health Services Human Growth Hormone Committee. Comparison of the intravenous insulin and oral clonidine tolerance test for growth hormone secretion. Arch Dis Child 1981;56:852-854.
27. Ferrer I, Pavia C, Valls C, Albarrán JM, Martín MR, Palou A. Estudio de la secreción adenohipofisaria en niños: comparación entre un test combinado y pruebas aisladas de estimulación. An Esp Pediatr 1984;21:119-123.